Routes of drug use among drug overdose deaths - United States, 2020-2022 - Tanz LJ, Gladden RM, Dinwiddie AT, Miller KD, Broz D, Spector E, O'Donnell J.
Preliminary reports indicate that more than 109,000 drug overdose deaths occurred in the United States in 2022; nearly 70% of these involved synthetic opioids other than methadone, primarily illegally manufactured fentanyl and fentanyl analogs (IMFs). Data... (Source: SafetyLit)
Source: SafetyLit - February 17, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: a model-based analysis - Qian G, Humphreys K, Goldhaber-Fiebert JD, Brandeau ML.
AIM: To assess the effectiveness and cost-effectiveness of buprenorphine and methadone treatment in the U.S. if exemptions expanding coverage for substance use disorder services via telehealth and allowing opioid treatment programs to supply a greater numb... (Source: SafetyLit)
Source: SafetyLit - February 12, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Praise for Final Methadone, Buprenorphine Rule Praise for Final Methadone, Buprenorphine Rule
A final federal rule that allows telehealth initiation of treatment and take-home doses of methadone increases access and removes stigma, say clinicians.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 8, 2024 Category: Drugs & Pharmacology Tags: Psychiatry Source Type: news

HHS Expands Access to Methadone, Buprenorphine
(MedPage Today) -- As part of a broader overdose prevention strategy, the Biden administration announced changes to decades-old federal rules, which aim to simplify and expand access to addiction treatment in order to save more lives. Specifically... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - February 2, 2024 Category: Psychiatry Source Type: news

Study Compares Safety of Two Common Treatments for Opioid Use Disorder During Pregnancy
A new study from Brigham and Women ’s Hospital, a founding member of the Mass General Brigham healthcare system, compared the risk of birth defects in OUD patients who are treated with buprenorphine and methadone during pregnancy. (Source: BWH News)
Source: BWH News - January 29, 2024 Category: Hospital Management Source Type: news

Evaluation of an educational intervention based on theory of planned behavior to reduce suicidal ideation and attempts in drug addicts receiving methadone: a quasi-experimental study - Najafi S, Razmjouie F, Shiraly R, Afzali Harsini P, Khani Jeihooni A.
BACKGROUND: Drug addiction can lead to suicidal ideation or suicide attempt so that half of those who attempt suicide have a history of substance abuse. The purpose of this study was to investigate the effect of educational intervention based on Theory of ... (Source: SafetyLit)
Source: SafetyLit - January 26, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Congenital Malformation Risk Lower With Buprenorphine Versus Methadone
THURSDAY, Jan. 25, 2024 -- The risk for congenital malformations is lower in association with buprenorphine versus methadone for opioid use disorder in pregnancy, according to a study published online Jan. 22 in JAMA Internal Medicine. Elizabeth A.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 25, 2024 Category: Pharmaceuticals Source Type: news

Buprenorphine Less Risky Than Methadone for Fetal Anomalies Buprenorphine Less Risky Than Methadone for Fetal Anomalies
For some women, especially those on stable treatment before pregnancy or women not responding well to buprenorphine, methadone may be the better choice, explain researchers.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 23, 2024 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care Source Type: news

Buprenorphine Less Risky for Most Birth Defects Than Methadone
(MedPage Today) -- The risk of congenital malformations appears to be lower with buprenorphine than with methadone when taken during the first trimester of pregnancy for opioid use disorder (OUD), according to an analysis of Medicaid data. In... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 22, 2024 Category: Psychiatry Source Type: news

Predictors of suicidal ideation and continued substance use problems among patients receiving methadone maintenance treatment who have co-occurring cocaine use disorder - Kelly LM, Alessi SM, Rash CJ, Zajac K.
BACKGROUND: Persons with polysubstance use problems are at high suicide risk, which may complicate substance use treatment. The purpose of this study was to a) examine cross-sectional and longitudinal risk factors for suicidality among persons in methadone... (Source: SafetyLit)
Source: SafetyLit - January 18, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Mindfulness-Oriented Recovery Enhancement Boosts Methadone Treatment
MONDAY, Jan. 8, 2024 -- Telehealth-delivered mindfulness-oriented recovery enhancement (MORE) is a feasible and effective adjunct to methadone treatment (MT) for individuals with opioid use disorder (OUD) and pain, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 8, 2024 Category: Pharmaceuticals Source Type: news

Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19 - Roy V, Buonora M, Simon C, Dooling B, Joudrey P.
BACKGROUND: Patients face well documented problems accessing methadone from opioid treatment programs (OTPs) in the U.S., yet addressing these barriers has proven difficult due in part to the sheer number of actors governing treatment, including state auth... (Source: SafetyLit)
Source: SafetyLit - January 8, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Trends in use of medicines for opioid agonist treatment in Australia, 2013-2022 - Bharat C, Chidwick K, Gisev N, Farrell M, Ali R, Degenhardt L.
This study describes 10-year trends in the sales of OAT medicines in Australia. METHODS: A descriptive and time-series analysis of methadone, su... (Source: SafetyLit)
Source: SafetyLit - December 1, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

California ’ s New Plan to Treat the Mentally Ill May End Up Violating Their Rights
Facing enormous pressure to tame what appears to be a spiraling and increasingly intertwined statewide crisis in mental health, substance use, and homelessness, California officials have created the Community Assistance, Recovery and Empowerment Court, or CARE Court. The new system is a policy smorgasbord that ranges from the provision of court-ordered treatment and housing to food assistance, social activities, and exercise programming for Californians with severe mental illness. CARE Court, which launched in October to skeptical but hopeful Californians, is aimed at tackling the Golden State’s perpetual public ...
Source: TIME: Health - November 29, 2023 Category: Consumer Health News Authors: Jerel Ezell Tags: Uncategorized California Source Type: news

Proposed Methadone Treatment Legislation May Put Patients at Risk
(MedPage Today) -- Overdoses in the U.S. due to opioids are hitting devastating new levels as high-potency synthetic opioids like fentanyl and metonitazene rack the nation. Medication-assisted treatment (MAT) for opioid use disorder is a life-saving... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - November 19, 2023 Category: Psychiatry Source Type: news